Question 1

What is Vaxcyte, Inc. Common Stock's WACC?

Accepted Answer

Vaxcyte, Inc. Common Stock (PCVX) has a Weighted Average Cost of Capital (WACC) of 7.70%. This is calculated using a Cost of Equity of 7.70% (via CAPM with a beta of 0.82) and a pre-tax Cost of Debt of 5.00%, with an equity weight of 100.00% in the capital structure.

Question 2

Is Vaxcyte, Inc. Common Stock's WACC high or low?

Accepted Answer

Vaxcyte, Inc. Common Stock's WACC of 7.70% is below the typical range of 8-12% for most companies, indicating relatively low cost of capital and lower risk. WACC is used as the discount rate in DCF valuations — a lower WACC results in higher present values of future cash flows.

Question 3

How is Vaxcyte, Inc. Common Stock's WACC calculated?

Accepted Answer

Vaxcyte, Inc. Common Stock's WACC is calculated using the formula: WACC = (E/V × Re) + (D/V × Rd × (1-T)). The Cost of Equity (Re) of 7.70% is derived from the CAPM model using a beta of 0.82. The pre-tax Cost of Debt (Rd) is 5.00%. The capital structure is 100.00% equity and 0.00% debt.

Vaxcyte, Inc. Common Stock (PCVX) — WACC 分析

WACC 构成

解读

Vaxcyte, Inc. Common Stock（PCVX）WACC：7.70%

WACC计算器

Vaxcyte, Inc. Common Stock（PCVX） WACC 解读

PCVX 公司分析

PCVX DCF 估值

继续做同行对比